Join
Live feed
·
INSIDERFilingvia Quantisnow
Eyegate Pharmaceuticals, Inc. logo

SEC Form 4: Romano Sarah disposed of $731 worth of Common Stock (177 units at $4.13), decreasing direct ownership by 0.74% to 23,756 units

ByQuantisnow·Wall Street's wire, on your screen.
EYEG· Eyegate Pharmaceuticals, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EYEG (Eyegate Pharmaceuticals, Inc.) and more on Quantisnow.